Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 9, 2017 - Issue
Submit an article Journal homepage
83
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients

Daniel Aletaha1 Division of Rheumatology, Department of Internal Medicine, Medical University of Vienna, Vienna, AustriaCorrespondence[email protected]
,
Sonya J Snedecor2 Pharmerit International, Bethesda, MD
,
Varun Ektare2 Pharmerit International, Bethesda, MD
,
Mei Xue2 Pharmerit International, Bethesda, MD
,
Yanjun Bao3 AbbVie Inc., North Chicago, IL, USA
&
Vishvas Garg3 AbbVie Inc., North Chicago, IL, USA
Pages 451-458 | Published online: 28 Jul 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.